Growing Environmental Concerns To Augment Bioplastic Packaging Market Growth

Bioplastic Packaging Market
Bioplastic Packaging Market

Bioplastic Packaging Market is estimated to be valued at US$ 10.60 Bn in 2021 and is expected to exhibit a CAGR of 29.34 % over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights

Market Overview:

Bioplastic packaging is a plastic packaging material derived from bio-based monomers and polyethylene (PE) derived from vegetable fats and oils, corn starch, wood chip, straw, and food waste. Bioplastic packaging is widely used in flexible packaging, rigid packaging, and food and beverage packaging.

Competitive Landscape:

Novamont S.p.A; Amcor plc; NatureWorks, LLC; Sealed Air; Coveris; Alpha Packaging; Mondi plc.; Constantia Flexibles Group GmbH; Transcontinental Inc.; and ALPLA

Key Market Drivers:

Growing awareness about environment and climate change among consumers, increasing government initiatives towards the use of biodegradable materials, and high demand for sustainable products among consumers is driving market growth.

The global Edible Packaging Market is anticipated to increase as a result of a growing demand to reduce packaging waste. Almost one-third of the rubbish in the world is packaging.

The rising demand for food packaging is also expected to drive the market growth over the forecast period. This is primarily due to the increasing number of restaurants and fast food joints in the world that use bioplastic sacks for their packaging requirements.

Covid-19 Impact Analysis

During Covid-19 pandemic the global bioplastic packaging industry has faced huge shutdown. Lockdown has negatively impacted industrial transform processes. Major disruption in supply chain and trading patterns in the global market has severely impacted the market growth.

Key Takeaways:

1. The Bioplastic Packaging Market is expected to exhibit a CAGR at higher rate over the forecast period owing the increasing consumption of plastic bottles and disposable cups and increasing number of restaurants and fast food joint.


2. North America region is anticipated to lead the market over the forecast period owing to the presence of developed economies and favorable government policies.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more